Jubilant Life Sciences gains on plan of raising Rs 1,000 crore via NCDs

29 Nov 2016 Evaluate

Jubilant Life Sciences is currently trading at Rs. 658.00, up by 2.00 points or 0.30% from its previous closing of Rs. 656.00 on the BSE.

The scrip opened at Rs. 659.65 and has touched a high and low of Rs. 668.50 and Rs. 655.05 respectively. So far 22554 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 705.05 on 01-Nov-2016 and a 52 week low of Rs. 272.50 on 20-Jan-2016.

Last one week high and low of the scrip stood at Rs. 676.90 and Rs. 607.50 respectively. The current market cap of the company is Rs. 10531.67 crore.

The promoters holding in the company stood at 54.02%, while institutions and non-institutions held 26.26% and 19.72% respectively.

Jubilant Life Sciences is seeking shareholders’ approval through postal ballot/e-voting to raise up to Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. Approval to the board to raise the amount also stipulates that this could be done in one or more series/tranches during a period of one year from the date of passing the resolution.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×